US Patent Issued to Oklahoma Medical Research Foundation, Seoul National University R&DB Foundation on Sept. 16 for "Monoclonal antibodies to ELTD1 and uses thereof" (South Korean, American Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,851, issued on Sept. 16, was assigned to Oklahoma Medical Research Foundation (Oklahoma City) and Seoul National University R&DB Foundation (Seoul, South Korea).

"Monoclonal antibodies to ELTD1 and uses thereof" was invented by Rheal A. Towner (Piedmont, Okla.) and Junho Chung (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to novel monoclonal antibodies that bind to ELTD 1 and methods for use thereof, including, detection and treatment of cancer, multiple sclerosis, retinopathy, or promoting tissue regeneration."

The patent was filed on Nov. 1, 2019, under Application No. 17/290,501.

*For fur...